reference strain e coli atcc 25922 (ATCC)

ATCC is a verified supplier

ATCC manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

ATCC reference strain e coli atcc 25922
Reference Strain E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 5027 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e+coli+atcc+25922+reference+strain/Klebsiella+quasipneumoniae+Brisse+et+al/pm42304017-155-6-10
Average 99 stars, based on 5027 article reviews

reference strain e coli atcc 25922 - by Bioz Stars, 2026-09

99/100 stars

Images

Activity Assay:

Article Title: Antimicrobial and anti-cancer potential of turmeric synthesized AuNPs and Chitosan-AuNP nanocomposites against MDR pathogens and breast/colorectal carcinoma cells.
Article Snippet: .. In addition, E. coli ESA253 and E. coli ATCC 25922 reference strain were more resistance than K. pneumoniae ESA254 and E. coli ESA253, and K. pneumoniae ATCC13883 (susceptible) to the green-synthesized Table 2 Antimicrobial activity of different concentrations (50, 100 and 150 μg/mL) of TAuNPs and NCS –TAuNPs conjugate against UTIs isolates; K. pneumoniae ESA254 and E. coli ESA253, and K. pneumoniae ATCC13883 and E. coli ATCC 25922 reference strains, compared with 10 μg/ml of Gentamycin and Augmentin antibacterial standards Concentrations (μg/ mL) Inhibition Zone (mm) K. pneumoniae ESA254 E. coli ESA253 K. pneumoniae ATCC13883 E. coli ATCC 25922 TAuNPs 50 10.4 ± 0.12 6.9 ± 0.1 10.5 ± 0.1 10.3 ± 0.11 100 12.0 ± 0.1 9.6 ± 0.12 10.8 ± 0.12 11.4 ± 0.12 150 14.3 ± 0.3 10.8 ± 0.23 12.9 ± 0.14 12.4 ± 0.13 NCS –TAuNPs 50 12.6 ± 0.05 11.5 ± 0.24 11.5 ± 0.11 11.5 ± 0.11 100 14.25 ± 0.12 12.5 ± 0.06 12.4 ± 0.14 14.4 ± 0.10 150 15.6 ± 0.2 13.3 ± 0.20 14.5 ± 0.13 15.7 ± 0.13 Gentamycin 10 16.9 ± 0.31 14.3 ± 0.12 15.1 ± 0.11 15.2 ± 0.11 Augmentin 10 16.25 ± 0.24 13.7 ± 0.13 13.8 ± 0.12 13.4 ± 0.14 Values are expressed as mean ± SE (n = 3) Fig. 4 The inhibition percentage of DPPH (a) and ABTS (b) free radicals assessed with various quantities of green-made TAuNPs and NCS-TAuNPs combined, with ascorbic acid as the positive standard TAuNPs and NCS-TAuNPs conjugate. ..

Inhibition:

Article Title: Antimicrobial and anti-cancer potential of turmeric synthesized AuNPs and Chitosan-AuNP nanocomposites against MDR pathogens and breast/colorectal carcinoma cells.
Article Snippet: .. The TAuNPs and NCS-TAuNPs showed the highest inhibition activities 14.5 ± 0.13 mm, 12.9 ± 0.14 mm against K. pneumoniae ATCC13883 reference strain exposed to 150 (μg/mL) of NCS-TAuNPs and TAuNPs, respectively, and 15.7 ± 0.13 mm and 12.4 ± 0.13 mm against E. coli ATCC 25922 reference strain exposed to 150 (μg/mL) of NCSTAuNPs and TAuNPs respectively, These values were lower compared to the inhibition zones of gentamycin (14.3 ± 0.12 mm) and Augmentin (13.7 ± 0.13 mm), respectively. ..

other:

Article Title: Antimicrobial and anti-cancer potential of turmeric synthesized AuNPs and Chitosan-AuNP nanocomposites against MDR pathogens and breast/colorectal carcinoma cells.
Article Snippet: While E. coli ESA253 isolate was susceptible to Azithromycin, Gentamicin and tetracycline, followed with ciprofloxacin, Chloramphenicol, ceftriaxone and Cefoxitin, and exhibited a resistance to ampicillin-sulbactam, Cefixime, Amikacin and ampicillin antibiotics, while K. pneumoniae ATCC13883 reference strain was susceptible to Ampicillin-sulbactam, Ciprofloxacin, Chloramphenicol, followed with Gentamicin, Amikacin, ceftazidime and Cefoxitin, and exhibited resistance to Cefixime, Azithromycin, ampicillin, ceftriaxone and tetracycline antibiotics, The E. coli ATCC 25922 reference strain was susceptible to Azithromycin, Ampicillin-sulbactam, Ciprofloxacin, ceftazidime, Cefoxitin and Amikacin, and exhibited a resistance to tetracycline, Cefixime and Ampicillin antibiotics, as shown in Supplementary Table S3.

Article Title: Isolation and Characterization of the New Lytic Bacteriophage KEC4 Against Escherichia coli MDR Strains
Article Snippet: In the first stage, the combined effect of antimicrobials with the bacteriophage was evaluated on the E. coli ATCC 25922 reference strain.

Article Title: Isolation and Characterization of the New Lytic Bacteriophage KEC4 Against Escherichia coli MDR Strains.
Article Snippet: In the first stage, the combined effect of antimicrobials with the bacteriophage was evaluated on the E. coli ATCC 25922 reference strain.

Control:

Article Title: High prevalence and co-existence of SHV and CTX-M genes in extensively drug-resistant (XDR) Gram-negative bacteria isolated from hospital settings in Faisalabad District, Pakistan.
Article Snippet: 1 Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering College, Pakistan Institute of Engineering and Applied Sciences (NIBGE-C, PIEAS), Jhang Road, Faisalabad, Pakistan 2 Department of Microbiology, Government College University, Faisalabad, Pakistan 3 Department of Pathology, Khawaja Muhammad Safdar Medical College, Sialkot, Pakistan 4 Microbiology Department, Medicine and Allied Specialties, Faisalabad Medical University, Allied Hospital, Faisalabad, Pakistan 5 Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia Abstract Background Hospital-acquired infections (HAIs) associated with increasing antimicrobial resistance (AMR) are becoming a global health challenge, causing AMR spread and a serious health threat.. This study was designed to evaluate the phenotypic and genotypic status of AMR in Gram-negative HAI-associated bacteria, to gain a current insight into the local settings.. Methods and Results Kirby-Bauer method and Double Disc Synergy Test were used for phenotypic assessment of AMR and extended-spectrum β-lactamase (ESBL) producers, respectively.

Review